Psychosocial factors in lung cancer: Quality of life, economic impact, and survivorship implications

Journal of Psychosocial Oncology

Volumn 26, Issue 1, 2007, Pages 69-80

  Pearman, Timothy ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Psychosocial factors; Quality of life; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ANOREXIA; BLOOD TOXICITY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL PRACTICE; COUGHING; DYSPNEA; ECONOMIC ASPECT; FATIGUE; FEBRILE NEUTROPENIA; HEALTH CARE SYSTEM; HEMOPTYSIS; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MEDICAL RESEARCH; NAUSEA; NEPHROTOXICITY; PAIN; PROGNOSIS; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY; STATISTICAL ANALYSIS; SURVIVAL RATE; UNITED STATES; VOMITING;

COST OF ILLNESS; HUMANS; LUNG NEOPLASMS; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; UNITED STATES;

EID: 37149044047     PISSN: 07347332     EISSN: 15407586     Source Type: Journal    
DOI: 10.1300/J077v26n01_05     Document Type: Review

References (45)

1. Aaronson, N.K., Ahmedzai, S., Bergman, B. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials of oncology. Journal of the National Cancer Institute, 85, 365-377.
2. Akechi, T., Nakano, T., Akizuki, N., Nakanishi, T., Yoshikawa, E., Okamura, H. & Uchitomi, Y. (2002). Clinical factors associated with suicidality in cancer patients. Japanese Journal of Clinical Oncology, 32(12), 506-511.
3. American Cancer Society Facts and Figures 2006 (2006). Atlanta, GA. American Cancer Society.
4. American Cancer Society: Cancer Facts and Figures 2004 (2004). Atlanta, GA, American Cancer Society.
5. Belvedere, O. & Grossi, F. (2005). To treat or not to treat advanced non-small cell lung cancer patients with impaired performance status? Journal of Clinical Oncology, 23(28), 7231-7232.
6. Bernhard, J., Hurny, C., Bacchi, M., Joss, R.A., Cavalli, F., Senn, H.J., Leyvraz, S., Stahel, R., Ludwig, C. & Alberto, P. (1996). Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). British Journal of Cancer, 74(10), 1660-1667.
7. Blackhall, F.H., Bhosle, J. & Thatcher, N. (2005). Chemotherapy for advanced nonsmall cell lung cancer patients with performance status 2. Current Opinions in Oncology, 17(2), 135-139.
8. Bordeleau, L & Goodwin, P.J. (2000). Economic issues in lung cancer. Seminars in Respiratory and Critical Care Medicine, 21(5), 375-384.
9. Bredin, M., Corner, J., Krishnasamy, M., Plant, H., Bailey, C. & A'Hern, R. (1999). Multicentre randomized controlled trial of nursing intervention to control breathlessness in patients with lung cancer. British Medical Journal, 318, 901-904.
10. Carlsen, K., Jensen, A.B., Jacobsen, E., Krasnik, M. & Johansen, C. (2005). Psychosocial aspects of lung cancer. Lung Cancer, 47(3), 293-300.
11. Cella, D. (2004). The Functional Assessment of Cancer Therapy-Lung and Lung Cancer Subscale assess quality of life and meaningful symptom improvement in lung cancer. Seminars in Oncology; 31(suppl. 9), 11-15.
12. Cella, D.F., Bonomi, A.E. & Lloyd, S.R. (1995). Reliability and validity of the Functional Assessment of Cancer Therapy Lung (FACT-L) quality of life instrument. Lung Cancer; 12, 199-220.
13. CDC (2002). Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States 1995-1999. MMWR, 51(14), 300-303.
14. D'Addario, G., Pintilie, M., Leighl, N.B., Feld, R., Cerny, T. & Shepherd, F.A. (2005). Platinum-based versus non-platinum-based chemotherapy in advanced non-small cell lung cancer: A meta-analysis of the published literature. Journal of Clinical Oncology, 23(13), 2926-2936.
15. DeVita, V.T., Hellman, S. & Rosenberg, S. (1993). Cancer: principles and practice of oncology (4th ed.). Philadelphia, PA. Lippincott.
16. Dharma-Wardene, M., Au, H.J., Hanson, J., Dupere, D., Hewitt, J. & Feeny, D. (2004). Baseline FACT-G score is a predictor of survival for advanced lung cancer. Quality of Life Research, 13(7), 1209-1216.
17. Ell, K., Nishimoto, R., Mantell, J. & Hamovitch, M. (1988). Longitudinal analysis among family members of patients with cancer. Journal of Psychosomatic Research, 32(4-5), 429-438.
18. Eton, D.T., Fairclough, D.L. & Cella, D. (2003). Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicated by baseline report: Results from Eastern Cooperative Oncology Group Study 5592. Journal of Clinical Oncology; 21, 1536-1543.
19. Earl, H.M., Rudd, R.M., Spiro, S.G., Ash, C.M., James, L.E. & Law, C.S. (1991). A randomized trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. British Journal of Cancer, 64, 566-572.
20. Earle, C.C. (2004). Outcomes research in lung cancer. Journal of the National Cancer Institute Monographs, 33, 56-77.
21. Fawzy, F.I. (1999). Psychosocial interventions for patients with cancer: What works and what doesn't. European Journal of Cancer, 35(11), 1559-1564.
22. Frasci, G., Comella, P., Panza, N., DeCataldis, G., Del Gaizo, F., Pozzo, C., Gravina, Al, Ruffolo, P., Cioffi, R., Marcatili, P., Della Vittoria, M., Monfardini, S. & Comella, G. (1998). Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia. European Journal of Cancer, 34(11), 1710-1714.
23. Gross, C.P. & Krumholz, H.M. (2005). Impact of managed care on cancer trial enrollment. Journal of Clinical Oncology, 23(16), 3811-3818.
24. Hollen, P.J., Gralla, R.J. & Cox, C. (1997). A dilemma in analysis: Issues in the serial measurement of quality of life in patients with advanced lung cancer. Lung Cancer, 18, 119-136.
25. Hollen, P.J., Gralla, R.J. & Kris, M.G. (1994). Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: Psychometric assessment of the Lung Cancer Symptom Scale. Cancer, 73, 2087-2098.
26. Kosty, M.P., Fleishman, S.B., Herndon, J.E., Coughlin, K., Kornblith, A.B. & Scalzo, A. (1994). Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. Journal of Clinical Oncology, 12, 1113-1120.
27. Kutikova, L., Bowman, L., Chang, S., Long, S.R., Obasaju, C. & Crown, W.H. (2005). The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer, 50(2), 143-154.
28. Li, W.W., Lee, T.W. & Yim, A.P. (2004). Quality of life after lung cancer resection. Thoracic Surgery Clinics, 14(3), 353-365.
29. Maslove, L., Gower, N., Spiro, S., Rudd, R., Stephens, R. & West, P. (2005). Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer. Thorax, 60(7), 564-569.
30. Mulshine, J.L. (2005). Clinical issues in the management of early lung cancer. Clinical Cancer Research, 11(13 pt. 2), 4993s-4998s.
31. Pfister, D.G., Johnson, D.H., & Azzoli, C.G. (2004). American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: Update 2003. Journal of Clinical Oncology, 22, 330-353.
32. Ramsey, S.D., Howlader, N., Etzioni, R.D. & Donato, B. (2004). Chemotherapy use, outcomes and costs for older persons with advanced non-small cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare. Journal of Clinical Oncology, 22(24), 4971-4978.
33. Rawl, S.M., Given, B.A., Given, C.W., Champion, V.L., Kozachik, S.L., Barton, D., Emsley, C.L. & Williams, S.D. (2002). Intervention to improve psychosocial functioning for newly diagnosed patients with cancer. Oncology Nursing Forum, 29(6), 967-975.
34. Regan, J., Yarnold, J., Jones, P.W. & Cooke, N.T. (1991). Palliation and life quality in lung cancer: how good are clinicians at judging treatment outcome. British Journal of Cancer, 64, 396-400.
35. Reis, L.A., Kosary, C.L., Hankey, B.F. & Miller, B.A., eds. (2004). SEER cancer statistics review, 1973-1996. Bethesda, MD: National Cancer Institute.
36. Roychowdhury, D.F., Desai, P. & Zhu, Y.W. (1997). Paclitaxel (3-hour infusion) followed by carboplatin (24 hours after paclitaxel): a phase II study in advanced non-small cell lung cancer. Seminars in Oncology, 24(Suppl 12), 37-40.
37. Sarna, L., Brown, J.K., Cooley, M.E., Williams, R.D., Chernecky, C., Padillo, G. & Danao, L.L. (2005). Quality of life and meaning of illness in women with lung cancer. Oncology Nursing Forum, 32(1), E9-19.
38. Sola, I., Thompson, E., Subirana, M., Lopez, C. & Pascual, A. (2004). Noninvasive interventions for improving well-being and quality of life in patients with lung cancer. Cochrane Database Systems Review, 18(4), CD004282.
39. Spiro, R.G., Rudd, R.M., Souhami, R.L., Brown, J., Fairlamb, D.J., Gower, N.H., Maslove, L., Milroy, R., Napp, V., Parmar, M.K., Peake, M.D., Stephens, R.J., Thorpe, H., Waller, D.A. & West, P. (2004). Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax, 59(10), 828-836.
40. Thatcher, N., Jayson, G., Bradley, B., Ranson, M. & Anderrson, H. (1997). Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer. Seminars in Oncology, 24(Suppl 8), 6-12.
41. Uchitomi, Y., Mikami, I., Kugaya, A., Nakano, T., Okuyama, T., Akechi, T. & Okamura, H. (2001). Physician support and patient psychologic responses after surgery for nonsmall cell lung carcinoma: a prospective observational study. Cancer, 92(7), 1926-1935.
42. Uchitomi, Y., Mikami, I., Nagai, K., Nishiwaki, Y., Akechi, T. & Okamura, H. (2003). Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer. Journal of Clinical Oncology 21(1), 69-77.
43. Warner, K.E., Hodgson, T.A. & Carroll, C.E. (1999). Medical costs of smoking in the United States: estimates, their validity and their implications. Tobacco Control, 8(3), 290-300.
44. Win, T., Laroche, C.M., Groves, A.M., Nathan, J., Clements, L. & Screaton, N.J. (2005). Re: The value of performing head CT in screening for cerebral metastases in patients with potentially respectable non-small cell lung cancer: experience from a UK cardiothoracic center. Clinical Radiology, 60(5), 620-621.
45. Zabora, J., Brintzenhofeszoc, K., Curbow, B., Hooker, C. & Piantadosi, S. (2001). The prevalence of psychological distress by cancer site. Psychooncology, 10(1), 19-28.